Biography
Dr. Atar Singh Kushwah is an Assistant Professor at Manipal University Jaipur and an internationally trained molecular geneticist specializing in translational oncology. His research integrates DNA repair, cancer epigenetics, and host–microbiome interactions to develop precision biomarkers and therapeutic strategies for women's cancers.
I investigate how DNA repair, epigenetic regulation, and host–microbiome interactions shape cancer evolution and therapeutic response. My goal is to translate molecular discoveries into clinically relevant biomarkers and precision therapies that improve patient outcomes.
Department of Biosciences, Manipal University Jaipur, India | Oct 2025–Present
Leading an independent research program focused on translational oncology, DNA repair biology, epigenetics, microbiome research, and precision medicine.
Board Member & Vice President
Life Sciences Institute of New Jersey (LSINJ), USA | 2023–Present
Contributing to interdisciplinary scientific leadership and collaborative initiatives in molecular genetics, epigenetics, genome biology, virology, and cancer-related research programs.
Women’s Biomedical Research Institute, Icahn School of Medicine at Mount Sinai, USA | 2023–2025
Investigated cervicovaginal microbiome-mediated epigenetic reprogramming and immune signaling in cervical and reproductive health using in vitro systems, mouse models, and human biospecimens. Research integrated molecular biology, immunology, and translational multi-omics approaches to study host–microbial interactions and therapeutic vulnerability.
Center for NanoBiotechnology Research, Alabama State University, USA | 2022–2023
Conducted research on antiviral immunosurveillance mechanisms and peptide-based therapeutic strategies using molecular, immunological, and translational experimental approaches, including flow cytometry, RNA sequencing, and in vivo imaging.
Senior Research Fellow
Molecular & Human Genetics Laboratory, University of Lucknow, India | 2016–2022
Conducted translational research on cervical cancer and metabolic disease, focusing on DNA repair alterations, oxidative stress, genetic susceptibility, and epigenetic mechanisms underlying disease progression and therapeutic response. Research involved molecular genetics, clinical sample analysis, bioinformatics, and translational biomarker studies.
Scientific Officer
Shantha Biotechnics Pvt. Ltd. (A Sanofi Company), India | 2014–2015
Worked in analytical process development and quality systems for vaccine manufacturing, including validation of analytical methods, regulatory compliance, and stability assessment of vaccine-associated biomaterials.